254 related articles for article (PubMed ID: 26782994)
1. Adverse reactions following administration of contrast media for diagnostic imaging in anaesthetized dogs and cats: a retrospective study.
Scarabelli S; Cripps P; Rioja E; Alderson B
Vet Anaesth Analg; 2016 Sep; 43(5):502-10. PubMed ID: 26782994
[TBL] [Abstract][Full Text] [Related]
2. Acute Adverse Events Following Gadolinium-based Contrast Agent Administration: A Single-Center Retrospective Study of 281 945 Injections.
McDonald JS; Hunt CH; Kolbe AB; Schmitz JJ; Hartman RP; Maddox DE; Kallmes DF; McDonald RJ
Radiology; 2019 Sep; 292(3):620-627. PubMed ID: 31264948
[TBL] [Abstract][Full Text] [Related]
3. Suspected anaphylactoid reaction following intravenous administration of a gadolinium-based contrast agent in three dogs undergoing magnetic resonance imaging.
Girard NM; Leece EA
Vet Anaesth Analg; 2010 Jul; 37(4):352-6. PubMed ID: 20636567
[TBL] [Abstract][Full Text] [Related]
4. Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients.
Erley CM; Bader BD; Berger ED; Tuncel N; Winkler S; Tepe G; Risler T; Duda S
Nephrol Dial Transplant; 2004 Oct; 19(10):2526-31. PubMed ID: 15280530
[TBL] [Abstract][Full Text] [Related]
5. Safety of gadobutrol, a new generation of contrast agents: experience from clinical trials and postmarketing surveillance.
Voth M; Rosenberg M; Breuer J
Invest Radiol; 2011 Nov; 46(11):663-71. PubMed ID: 21623211
[TBL] [Abstract][Full Text] [Related]
6. Effect of Extrinsic Warming of Low-Osmolality CT Contrast Media (Iohexol 350) on Extravasations and Patient Reaction Rates: A Retrospective Study.
Basharat NF; Ranganathan K; Kang PT; Gridley DG; Roh AT
AJR Am J Roentgenol; 2022 Jan; 218(1):174-179. PubMed ID: 34319163
[No Abstract] [Full Text] [Related]
7. Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions.
Wang CL; Cohan RH; Ellis JH; Caoili EM; Wang G; Francis IR
AJR Am J Roentgenol; 2008 Aug; 191(2):409-15. PubMed ID: 18647910
[TBL] [Abstract][Full Text] [Related]
8. Safety of Blood Pool Contrast Agent Administration in Children and Young Adults.
Rigsby CK; Popescu AR; Nelson P; Orr RJ; Boylan EE; Schoeneman S; deFreitas RA
AJR Am J Roentgenol; 2015 Nov; 205(5):1114-20. PubMed ID: 26496560
[TBL] [Abstract][Full Text] [Related]
9. Frequency of late allergy-like adverse reactions following injection of intravascular non-ionic contrast media. A retrospective study comparing a non-ionic monomeric contrast medium with a non-ionic dimeric contrast medium.
Rydberg J; Charles J; Aspelin P
Acta Radiol; 1998 May; 39(3):219-22. PubMed ID: 9571932
[TBL] [Abstract][Full Text] [Related]
10. Single-Center Retrospective Analysis of Breakthrough Allergic-Like Reactions to Gadobutrol.
Walker D; Chakraborty S; Schieda N
Invest Radiol; 2019 Jul; 54(7):448-451. PubMed ID: 30883457
[TBL] [Abstract][Full Text] [Related]
11. Adverse reactions following administration of an ionic iodinated contrast media in anesthetized dogs.
Vance A; Nelson M; Hofmeister EH
J Am Anim Hosp Assoc; 2012; 48(3):172-5. PubMed ID: 22474043
[TBL] [Abstract][Full Text] [Related]
12. Negligible Risk of Acute Renal Failure Among Hospitalized Patients After Contrast-Enhanced Imaging With Iodinated Versus Gadolinium-Based Agents.
Gorelik Y; Yaseen H; Heyman SN; Khamaisi M
Invest Radiol; 2019 May; 54(5):312-318. PubMed ID: 30480553
[TBL] [Abstract][Full Text] [Related]
13. Allergic-like Reactions to the MR Imaging Contrast Agent Gadobutrol: A Prospective Study of 32 991 Consecutive Injections.
Power S; Talbot N; Kucharczyk W; Mandell DM
Radiology; 2016 Oct; 281(1):72-7. PubMed ID: 27110731
[TBL] [Abstract][Full Text] [Related]
14. Adverse events with universal use of iodixanol for CT: comparison with iohexol.
Ho AL; O'Malley ME; Tomlinson GA
J Comput Assist Tomogr; 2007; 31(2):165-8. PubMed ID: 17414747
[TBL] [Abstract][Full Text] [Related]
15. 1-molar gadobutrol as a contrast agent for computed tomography: results from a comparative porcine study.
Kalinowski M; Kress O; Wels T; Alfke H; Klose KJ; Wagner HJ
Invest Radiol; 2003 Apr; 38(4):193-9. PubMed ID: 12649642
[TBL] [Abstract][Full Text] [Related]
16. Safety profile and protocol prevention of adverse reactions to uroangiographic contrast media in diagnostic imaging.
Rossi C; Reginelli A; D'Amora M; Di Grezia G; Mandato Y; D'Andrea A; Brunese L; Grassi R; Rotondi A
J Biol Regul Homeost Agents; 2014; 28(1):155-65. PubMed ID: 24750802
[TBL] [Abstract][Full Text] [Related]
17. Safety of gadobutrol in more than 1,000 pediatric patients: subanalysis of the GARDIAN study, a global multicenter prospective non-interventional study.
Glutig K; Bhargava R; Hahn G; Hirsch W; Kunze C; Mentzel HJ; Schaefer JF; Willinek W; Palkowitsch P;
Pediatr Radiol; 2016 Aug; 46(9):1317-23. PubMed ID: 27041276
[TBL] [Abstract][Full Text] [Related]
18. Clinical observation of the adverse drug reactions caused by non-ionic iodinated contrast media: results from 109,255 cases who underwent enhanced CT examination in Chongqing, China.
Li X; Chen J; Zhang L; Liu H; Wang S; Chen X; Fang J; Wang S; Zhang W
Br J Radiol; 2015 Mar; 88(1047):20140491. PubMed ID: 25582519
[TBL] [Abstract][Full Text] [Related]
19. In vitro histamine release induced by magnetic resonance imaging and iodinated contrast media.
Baxter AB; Lazarus SC; Brasch RC
Invest Radiol; 1993 Apr; 28(4):308-12. PubMed ID: 7683008
[TBL] [Abstract][Full Text] [Related]
20. Severe reaction to intravenous administration of an ionic iodinated contrast agent in two anesthetized dogs.
Pollard RE; Pascoe PJ
J Am Vet Med Assoc; 2008 Jul; 233(2):274-8. PubMed ID: 18627231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
